Hi, what are you looking for?
– Bristol-Myers Squibb’s Baraclude has $314 million in US annual sales. – Please help us out : Will you offer us a hand? Every...
– Eyal Desheh: There are many small US companies developing complex generic products. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is eying small acquisitions...
– Philips Israel chief Guido Pardo Roques: The incubator will also do medical devices. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Philips...
– Teva Pharmaceuticals has been sued by the City of Chicago for its prescription pain killers. – – The Israeli pharmaceutical giant Teva is...
– Adds Significant New Dimension to Teva’s Growing Pain Care Franchise. Peak sales potential of $2-3 billion. – – Teva Pharmaceutical Industries Ltd., (NYSE:TEVA)...
– Enabling the Global Integration of the Company and Positioning It for Short- and Long-Term Value Creation. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA)...
– Teva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex Capsules. – – Teva Pharmaceutical Industries...
– Teva investors are concerned about competition to the company’s Copaxone medication now that its patent has expired. Due to its failed attempt recently...
– Two California counties have filed a law suit against a number of pharmaceutical companies for allegedly promoting pain killer addiction. – California’s Orange...
– Mylan CEO Heather Bresch: Teva’s suit against the FDA was simply a desperate, last minute tactic. – – “We continue to see no...